How different cancer cells respond to drug-delivering nanoparticles

Using nanoparticles to deliver cancer drugs offers a way to hit tumors with large doses of drugs while avoiding the harmful side effects that often come with chemotherapy. However, so far, only a handful of nanoparticle-based cancer drugs have been FDA-approved.

A new study from MIT and Broad Institute of MIT and Harvard researchers may help to overcome some of the obstacles to the development of nanoparticle-based drugs. The team’s analysis of the interactions between 35 different types of nanoparticles and nearly 500 types of cancer cells revealed thousands of biological traits that influence whether those cells take up different types of nanoparticles.

Nanosynth Group plc (LON:NNN) nano-technology business that originated in Nottingham from a partnership with Nottingham Trent University. Their core mission is to develop unique ways to produce and apply nano particles.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Share on facebook
    Facebook
    Share on twitter
    Twitter
    Share on linkedin
    LinkedIn
    Nanosynth Group plc

    More articles like this

    Nanosynth Group plc

    Nanotechnology in the nutricosmetics industry

    Nanotechnology for Nutricosmetics Nanocarriers are ubiquitous within nanomedicine; however, with skin quality and health in high demand for consumers, these fields have overlapped. The use of nanotechnology and nanoformulations as delivery systems for improving the performance of active

    Nanosynth Group plc

    Nanotechnology in cosmetics

    Nanotechnology is the science of manipulating atoms and molecules in the nanoscale – 80,000 times smaller than the width of a human hair. The world market for products that contain nanomaterials is expected to reach $2.6 trillion by

    Nanosynth Group plc

    nanosynth group enter funding arrangements with Lanstead

    nanosynth Group plc (LON:NNN), the AIM quoted company specialising in the synthesis and application of nanoparticles to create new and improve existing products, has announced a conditional subscription to raise £2,942,500 through the issue of 535,000,000 new ordinary shares

    Nanosynth Group plc

    Nanoparticles boost anti-cancer immunity

    The growth of epithelial ovarian cancer, one of the most lethal malignancies, is associated with the presence of tumor-associated macrophages (TAMs), white blood cells that can block the anti-cancer activity of the immune system and immunotherapy. Fortunately, TAMs

    Nanosynth Group plc

    Improving crop resilience with nanoparticles

    Materials that can carry CRISPR gene-editing into plant cells could be key in the fight against global hunger. There were sceptics when Michael Strano and his colleagues published their method for using nanoparticles to alter the biology of

    Nanosynth Group plc

    How silicate nanoparticles help save historic buildings

    Constructions made of porous rock may weather over time. TU Wien (Vienna) researchers have now thoroughly examined how silicate nanoparticles can help save them for the first time. Several historical buildings were made of limestone, such as Vienna’s St. Stephen’s

    Nanosynth Group plc

    Nanoparticles can save historic buildings

    Many historical buildings were built of limestone, such as Vienna’s St. Stephen’s Cathedral. Limestone is easy to work with, but does not withstand weathering well. It consists mainly of calcite minerals that are relatively weakly bound to each

    Nanosynth Group plc

    Role of nanotechnology in management of plant viral diseases

    Plant viral diseases create massive economic damages and endanger the sustainability of agriculture. Nanotechnology is an emerging agronomy technique for plant viral disease control as nanoparticles can be utilized in pest control systems as nano insecticides, medicine delivery

    Nanosynth Group plc

    Nanoparticles can be triggered to release anti-cancer microRNA

    Study shows that nanoparticles release an anti-cancer microRNA inside lung cancer cells when stimulated using an alternating magnetic field. Researchers are pursuing ever-more sophisticated treatments to tackle lung cancer. Traditional chemotherapy can have serious side-effects throughout the body,

    Nanosynth Group plc

    Nanosynth Group “rapid progress is being made”

    Nanosynth Group plc (LON:NNN), the AIM quoted company specialising in the synthesis and application of nanoparticles to create new and improve existing products, has announced a strategic update further to its notification of 1 June 2022. The business

    Nanosynth Group plc

    Nanosynth AGM to be held on 26 July 2022

    Nanosynth Group plc (LON:NANO) the AIM quoted company specialising in the synthesis and application of nanoparticles to create new and improve existing products, announces that the date of the Company’s AGM has been changed. The Company’s Annual General

    Nanosynth Group plc

    Nanosynth Group new name, new board and new direction

    Nanosynth Group plc (LON:NNN), the AIM quoted company specialising in the synthesis and application of nanoparticles to create new and improve existing products, has announced its final audited results for the year ended 31 December 2021. The Company

    Nanosynth Group plc

    What are nanoparticles?

    A nanoparticle is a small particle that ranges between 1 to 100 nanometres in size. Undetectable by the human eye, nanoparticles can exhibit significantly different physical and chemical properties to their larger material counterparts. The definition given by

    No more posts to show